Pediatric Updates: Pharmacology: Abused and Controlled Substances
From neonates to teens, from primary to acute care, this module explores a variety of abused and controlled substances to benefit APRN learning and support patient care. You’ll learn about a wide range of topics, including: neonatal abstinence syndrome, opioid, cannabis, and hallucinogen use disorders, stimulant abuse, inhalants, poisoning, and more.
7.5 pharmacology contact hours accredited by NAPNAP (2.0 related to psychopharmacology) (6.0 related to controlled substances).
Answers are due 150 days from order process date.
What references are included?
12 online PDF articles or web resources (included/provided) to support answering all 36 questions.
Special notes about this module
PC and AC content included: This module contains both primary care- and acute care-focused topics and applications. Online articles support your learning even if you do not work in both specialty areas.
Considering this CE for your board CS hours requirement? This module was not created to satisfy specific controlled substance contact hour requirements as mandated by certain states and does not adhere to individual state regulations or laws. It is the responsibility of the APRN to be familiar with their state’s legislation regarding prescribing, monitoring, and dispensing of controlled substances.
No impact on your prescriptive authority: Completing this module does not change a practitioner's scope of practice or prescriptive authority as defined by your state/province board of nursing. The authority granted to APRNs for prescribing controlled substances is defined by your state/province board of nursing and may be further delineated by your institution or practice site. Pediatric APRNs and other providers can use this module to validate and/or increase their knowledge about controlled substances, substances of abuse, and prescribing for treatment of selected substances of abuse. Even if the topics discussed in the module are not applicable to your specific current practice or patient population, the information you learn can expand and strengthen your APRN knowledge.
Q. An adolescent with opioid use disorder has completed an inpatient treatment program for detoxification and is being transitioned to outpatient management. As part of a comprehensive approach to prevent relapse, which medication is MOST appropriately prescribed? A. clonidine B. naloxone C. naltrexone D. trazodone